VINOD K. RUSTGI, M.D.; JAY H. HOOFNAGLE, M.D.; JOHN L. GERIN, Ph.D.; EDWARD P. GELMANN, M.D.; CHERYL M. REICHERT, M.D., Ph.D.; JAMES N. COOPER, M.D.; ABE M. MACHER, M.D.
The acquired immunodeficiency syndrome has become a major phenomenon during the last 3 years. Recent data from several sources suggest that the syndrome may be a result of infection with a new human T-cell lymphoma virus (HTLV-III) (1). The relationship between the immune deficiency and the attendant opportunistic infections and neoplasms may lead to fundamental clues about the role of the immune system in health and disease. The populations that are at high risk for the development of this syndrome are also at high risk of developing hepatitis
RUSTGI VK, HOOFNAGLE JH, GERIN JL, GELMANN EP, REICHERT CM, COOPER JN, et al. Hepatitis B Virus Infection in the Acquired Immunodeficiency Syndrome. Ann Intern Med. ;101:795–797. doi: 10.7326/0003-4819-101-6-795
Download citation file:
Published: Ann Intern Med. 1984;101(6):795-797.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use